SpaceX Crew-12: Testing On-Demand IV Fluid Generation and Bacterial Growth on the ISS

Science in Microgravity

The launch of Crew-12 marks a shift in ISS research toward long-duration deep-space sustainability...

Mission Objectives & Implementation:

• IVGEN Breakthrough: Testing a system that generates medical-grade IV fluid from ISS waste water—critical for Mars missions where carrying liters of fluid is impossible.
• Pneumonia Pathogenesis: Analyzing how Streptococcus pneumoniae behaves in microgravity to develop more effective vaccines for astronauts.
• Blood Flow Mapping: Using high-resolution ultrasound to track how zero-G shifts fluid toward the head, a major cause of visual impairment in long-term crews.

Strategic Industry Impact:

The success of IVGEN will determine the medical viability of the 2030 Mars mission. If Crew-12 can prove stable, on-demand medical production, it removes one of the final 'red-level' risks for interplanetary travel.